Blood Diseases Market Research Reports & Industry Analysis
Blood Diseases Industry Research & Market Reports
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034
... of care that involves the prescription of riluzole has been effective in slowing the disease progression, thereby increasing the life span of patients. The most recent development in ALS was the addition of RELYVRIO for ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034
... common among adults, with a peak incidence between 50 and 70 years. The median age at onset is 52 years. As per the secondary research, the prevalence of wAIHA is 1 per 8,000, and accounts ... Read More
-
Global Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... market, the Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Anemia Therapeutics ... Read More
-
Cell and Gene Therapies in Hemophilia A & B
... analyst consensus forecasts, likelihood of approval analysis, and commentary on current and future players. The report also includes outlook from four key opinion leaders in the 5EU, US, and China and analyzes key unmet needs ... Read More
-
Sickle Cell Anemia Therapeutics Industry Research Report 2024
... The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). Highlights The global Sickle Cell Anemia Therapeutics market is ... Read More
-
Global Alpha Thalassemia Market Growth (Status and Outlook) 2024-2030
... market, the Alpha Thalassemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alpha Thalassemia ... Read More
-
Global Acquired Aplastic Anemia Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Acquired Aplastic Anemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
... Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Global Rare Hemophilia Factors Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Rare Hemophilia Factors is forecast to a readjusted size of US$ 242.3 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential ... Read More
-
Global Thalassemia Market Growth (Status and Outlook) 2024-2030
... the Thalassemia is forecast to a readjusted size of US$ 5324.4 million by 2030 with a CAGR of 8.8% during review period. The research report highlights the growth potential of the global Thalassemia market. Thalassemia ... Read More
-
Iron Deficiency Anemia Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... to reach USD 4.84 billion by 2029, growing at a CAGR of 5.60% during the forecast period (2024-2029). The COVID-19 pandemic had a significant impact on the healthcare systems, with significant consequences not only for ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Renal Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2024
... Surgical Centers; Multispecialty Clinics; Cancer Research Centers; Cancer Rehabilitation CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG Chemotherapy-Induced Anemia Global Market Report 2024 from The Business Research ... Read More
-
Thalassemia Drugs Global Market Report 2024
... Inc.; Merck & Co. Inc.; Novartis AG; Sanofi S.A.; Fresenius Kabi AG Thalassemia Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Australia and New Zealand Anemia in Pregnancy Market Report and Forecast 2024-2032
... and New Zealand anemia in pregnancy market size is anticipated to grow at a CAGR of 8.6% during the forecast period of 2024-2032, driven by the rising incidence of pregnancies across the region. Anemia in ... Read More
-
Hemophilia B - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
2024 Global Forecast for Hemophilia Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
Hemophilia A - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034
... areflexia are also observed in some cases. Limited knowledge regarding pathophysiology, disease severity, and consequences is impeding the development of effective treatments for Usher Syndrome. People who have Usher Syndrome are born with it, but ... Read More
-
Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034
... rare and severe nonmalignant disease characterized by autoimmune destruction of early hematopoietic cells. Its global incidence rate ranges from 0.7–7.4 cases per million inhabitants per year, with higher rates in Asia compared to Europe and ... Read More
-
China Genetic Testing Market Report by Test Type (Prenatal Testing, Carrier Testing, New Born Testing, Predictive/Presymptomatic Testing, Diagnostic Testing, and Others), Disease (Cancer, Down Syndrome, Thalassemia, and Others), Technology (Biochemical, Molecular, Cytogenetic), Service Provider (Hospital Based Laboratories, Independent Laboratories, Specialty Clinics), Testing Sample (Blood, Saliva, Hair, and Others) 2024-2032
... Based Laboratories, Independent Laboratories, Specialty Clinics), Testing Sample (Blood, Saliva, Hair, and Others) 2024-2032 The China genetic testing market size reached US$ 4.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach ... Read More
-
Iron Deficiency Anemia Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030
... the hospital, clinic, and home healthcare markets. The global iron deficiency anemia therapy market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major ... Read More
-
Thalassemia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
... laboratory markets. The global thalassemia treatment market is expected to reach an estimated $12.2 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are the increased ... Read More
-
Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2024-2030
... and expected to reach USD 17.62 billion in 2024, at a CAGR 8.74% to reach USD 29.26 billion by 2030. Global Bone Marrow Transplantation Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Chemotherapy Induced Anemia Market by Range Of Anemia (Life-Threatening Anemia, Mild Anemia, Moderate Anemia), Treatment (Erythropoiesis-Stimulating Agents, Iron Supplementation, RBC Transfusions), Drug, End-User - Global Forecast 2024-2030
... at USD 2.51 billion in 2023 and expected to reach USD 2.70 billion in 2024, at a CAGR 7.36% to reach USD 4.14 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
Research Assistance
